Media Type: Read

Financial markets have started the year on a weak note, what’s behind the moves and how are we seeing things?
Interest

A promising new drug therapy for those with Rett Syndrome
In December, Neuren Pharmaceuticals and its partner Acadia Pharmaceuticals announced positive

Portfolio Manager Mark Riggall discusses the month’s key highlights in 60 seconds.
A wider perspective
Fund returns in December were strong as

Profiting from Management Spin? Opportunities presented by corporate demergers
Breaking up is hard to do. But that is the journey on

Portfolio Manager Mark Riggall discusses the month’s key highlights in 60 seconds.
Omicron the headline, interest rates remain the real story
November

Investment Analyst Katlyn Parker discusses the investment opportunities we found in the hard-hit airport sector.
Investment Highlight: Australasian Airports – Moving

In 2021, many of us piled into a buoyant share market using our pent-up savings. But investors might see lower

Global bond yields have moved higher this year in anticipation of tightening central bank monetary policy. What has been somewhat